PDPN and neoplasm: PMab-117-mG2a also elicited more potent ADCC against endogenous PDPN expressing tumor PC-10 (42.1% cytotoxicity; p < 0.01) and LN319 (23.9% cytotoxicity; p < 0.01) cells.